Burning Issues with Head and Neck Cutaneous Oncology

This panel addresses the emerging evidence transforming the care of advanced head and neck cutaneous malignancy patients, from neoadjuvant and adjuvant immunotherapies to response adaptive surgery and modern approaches to radiation treatment and sentinel node biopsy. The speakers answer some of the burning questions in this rapidly changing field of clinical study and practice change.

Target Audience

This meeting was designed to meet the interests of medical oncologists, radiation oncologists, surgeons, physicists, nurses, diagnostic radiologists, pathologists, radiation therapists, radiation dosimetrists, speech language pathologists/scientists, dentists, oral surgeons, swallowing and speech therapists, audiologists, physical therapists, scientists, immunologist and rehabilitation specialists.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Recommend sentinel node biopsy to appropriate cutaneous malignancy patients and discuss merits and expectations with patients knowledgeably.
  • Describe the evidence supporting the use of neoadjuvant and adjuvant immunotherapies in advanced cutaneous oncology and apply it in practice.
  • Understand the concept of response-adaptive surgery, implications for radiation therapy and overall impact to coordinated multidisciplinary care.
Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.50 Certificate of Attendance
    This activity was designated for 1.50 AMA PRA Category 1 Credit™.
Course opens: 
02/09/2026
Course expires: 
03/01/2028
Cost:
$0.00
Part of: 
2026 Multidisciplinary Head and Neck Cancers Symposium onDemand
Rating: 
0

All relevant relationships have been mitigated.

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Available Credit

  • 1.50 AMA PRA Category 1 Credit™

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.50 Certificate of Attendance
    This activity was designated for 1.50 AMA PRA Category 1 Credit™.

Price

Cost:
$0.00
Please login or register to take this course.